UA88272C2 - Use of polypeptides of the cupredoxin family in cancer therapy - Google Patents
Use of polypeptides of the cupredoxin family in cancer therapyInfo
- Publication number
- UA88272C2 UA88272C2 UAA200602804A UAA200602804A UA88272C2 UA 88272 C2 UA88272 C2 UA 88272C2 UA A200602804 A UAA200602804 A UA A200602804A UA A200602804 A UAA200602804 A UA A200602804A UA 88272 C2 UA88272 C2 UA 88272C2
- Authority
- UA
- Ukraine
- Prior art keywords
- polypeptides
- cancer therapy
- cupredoxin family
- methods
- cell death
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Cytotoxic factors having use in modulating cell death, and their use in methods of treating necrosis or apoptosis-related conditions are disclosed. The invention also relates to methods for identifying active agents useful in treating conditions related to cell death or uncontrolled growth.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41455003P | 2003-08-15 | 2003-08-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA88272C2 true UA88272C2 (en) | 2009-10-12 |
Family
ID=37390765
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200602804A UA88272C2 (en) | 2003-08-15 | 2004-08-10 | Use of polypeptides of the cupredoxin family in cancer therapy |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN1863545A (en) |
UA (1) | UA88272C2 (en) |
ZA (1) | ZA200602126B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7491394B2 (en) | 2001-02-15 | 2009-02-17 | The Board Of Trustees Of The University Of Illinois | Cytotoxic factors for modulating cell death |
AU2018328223A1 (en) * | 2017-09-05 | 2020-03-12 | GLAdiator Biosciences, Inc. | Delivery of payloads to stem cells |
CN113912675B (en) * | 2021-09-23 | 2023-04-11 | 中国药科大学 | Centipede polypeptide with analgesic activity and application thereof |
-
2004
- 2004-08-10 CN CN 200480029453 patent/CN1863545A/en active Pending
- 2004-08-10 UA UAA200602804A patent/UA88272C2/en unknown
-
2006
- 2006-03-14 ZA ZA200602126A patent/ZA200602126B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1863545A (en) | 2006-11-15 |
ZA200602126B (en) | 2007-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN06059A1 (en) | Use of polypeptides of the cupredoxin family in cancer therapy | |
WO2003103581A3 (en) | Compositions and methods for liver growth and liver protection | |
WO2004030627A3 (en) | Synergistic methods and compositions for treating cancer | |
WO2009064590A3 (en) | Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer | |
EP1551812A4 (en) | Mitotic kinesin inhibitors | |
EP1463733A4 (en) | Mitotic kinesin inhibitors | |
EP1481077A4 (en) | Mitotic kinesin inhibitors | |
MY130363A (en) | "pyrrole substituted 2-indolinone protein kinase inhibitors" | |
MXPA06000933A (en) | Aminopyrazole compounds and use as chk1 inhibitors. | |
WO2002076380A3 (en) | Cytotoxic factors for modulating cell death | |
TW200502385A (en) | Modulation of forkhead box o1a expression | |
UA84954C2 (en) | Fused pyrimidones usefuel in the treatment and the prevention of cancer | |
IL178042A0 (en) | Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation | |
AU5173501A (en) | Polyamine analogues as cytotoxic agents | |
HK1033910A1 (en) | Use of erythropoietin in the treatment of multiple myeloma | |
ATE469659T1 (en) | STIBOGLUCONATE SODIUM AND IL-2 FOR CANCER TREATMENT | |
AU2002350623A1 (en) | Targeted thrombosis by tissue factor polypeptides | |
ATE287722T1 (en) | AGENT FOR TREATING MALIGNANT DISEASES USING THE PROTEIN YB-1 | |
HK1074840A1 (en) | Novel dithiolopyrrolones with therapeutic activity | |
UA88272C2 (en) | Use of polypeptides of the cupredoxin family in cancer therapy | |
HK1079116A1 (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy | |
UA88294C2 (en) | Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation | |
WO2005094282A3 (en) | Combination therapy comprising cloretazinetm | |
WO2004053054A3 (en) | Nk cell receptor conjugates for treating malignancies | |
WO2000074667A3 (en) | Compositions active in telomere damage comprising a taxane and telomerase inhibitor |